Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

Radhika Gogoi, M.D., receives Geri Fournier Ovarian Cancer Research Grant

Karmanos is pleased to congratulate Radhika Gogoi, M.D., Ph.D. , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos for securin...

Read More

FDA approval granted for new breast imaging tool developed in Detroit

SoftVue™ 3D Whole Breast Ultrasound Tomography System developed by Karmanos Cancer Institute spinoff Delphinus Medical Technologies, LLC Karmanos ...

Read More

Karmanos Cancer Institute receives 2021 Prostate Cancer Foundation Challenge Award

Karmanos is pleased to announce that it has received a Movember – Prostate Cancer Foundation PCF Challenge Award totaling $1 million. PCF Challeng...

Read More
News

ACS CAN Michigan Candid Connection, August 2021 — April Brown

Listen Now

Dr. Al Hallak on alcohol and cancer with WJR

Listen Now

ACS CAN MI CANdid Connection, July 2021 — Anthony Shields, M.D.

Listen Now